Importance The high cost of cancer medicines is a public health challenge. Policy makers in
the US and Europe are debating reforms to drug pricing that would cover both the prices of …

Objectives Rising cancer drug prices challenge patients and healthcare systems. Although
prices are routinely assigned to original drug indications receiving US Food and Drug …

Purpose Cancer drug prices at launch have increased in recent years. It is unclear how
individual drug prices change over time after launch and what market determinants …

The cost of treating cancer has risen to unprecedented heights, putting tremendous financial
pressure on patients, payers, and society. Previous studies have documented the rising …

Background Rising cancer drug prices adversely affect patients' adherence and survival.
Objective We aimed to identify and quantify factors associated with launch prices and post …

Background Increasing cancer drug prices are a challenge for patients and health systems
in the USA and Europe. By contrast with the USA, national authorities in European countries …

Methods| TruvenHealth MarketScan outpatient prescription drug data from January 1, 2000,
through December 31, 2014, were used to identify claims for dispensed orally administered …

All countries are struggling with the financial burden associated with cancer and its
treatment. Worldwide, drugs associated with cancer care are estimated to cost …

Background Prices of anti-cancer drugs are skyrocking. We aimed to assess the clinical
benefit of new drugs for treating advanced solid tumors at the time of their approval by the …

Background Cancer drugs are a major component of pharmaceutical spending in the USA
and Europe. The number of approved cancer drugs continues to increase. More new drugs …